CBD Monthly Update — December 2019

FDA’s new guidance worries industry

The agency’s new consumer guidance document on CBD overstates its risks and undersells its benefits, say industry leaders. The Consumer Update says the FDA can’t conclude that CBD is safe for use in human or animal food. Read more at Hemp Supporter...

15 companies received warning letters

The FDA sent letters to 15 privately held CBD companies concerning violations including marketing unapproved new human and animal drugs, selling CBD products as dietary supplements and adding CBD to foods for people and animals. Read more at FDA.gov...

Bluebird Botanicals earns B Corp Certification

Bluebird Botanicals, a family-owned, industry-leading manufacturer and distributor of high-quality hemp extracts, CBD oils and topicals, announces they have officially become a Certified B Corporation^®. This certification means they meet the highest standards of social and environmental performance, public transparency, and legal accountability to balance profit and purpose. Read more at Yahoo News...

Canopy finally enters US market

This month, Canopy Growth—the world’s largest cannabis company, worth about $6.4 billion—quietly launched its new CBD brand, First & Free, in the United States. Learn more at Yahoo News...

Study reveals rampant mislabeling

Leafly partnered with an independent lab to test 47 CBD products and found that 51% contained the promised CBD within 20% of the labeled dosage, 23% had some CBD but less than 80% of the promised dosage, 15% had more than 120% of the labeled dosage and 11% had no CBD whatsoever. Read more at Leafly...

Want to receive these updates directly to your inbox each month? Sign up here, and also get a copy of Demystifying CBD, one question at a time.